Oruka Therapeutics, Inc. (ORKA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $34.32
• Market Cap: $1.71B
• 52-Week High: $36.53
• 52-Week Low: $5.49

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. is a forward-thinking biotechnology company dedicated to advancing innovative therapies that address critical medical needs across a range of chronic and complex diseases. By harnessing state-of-the-art research and development resources, the firm is positioned to bring transformative treatment solutions to market. With a robust pipeline of promising product candidates and a steadfast commitment to scientific rigor, Oruka Therapeutics is well-equipped to drive meaning...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Oruka Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ORKA pay dividends?

Oruka Therapeutics, Inc. (ORKA) does not currently pay a regular dividend.

What is ORKA's market cap?

Oruka Therapeutics, Inc. (ORKA) has a market capitalization of $1.71B with a current stock price of $34.32.